chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received 1st dose on 11/10/21 of pediatric dose instead of the adult dose of Pfizer vaccine. He then received his second dose on 12/1/21 of the pediatric dose of Pfizer instead of the adult dose. A call was placed to Pfizer who stated that they follow the CDC guidelines which would require this patient to receive a 3rd dose of the adult Pfizer 21 days from 12/1/21 to be considered fully vaccinated. Mom was contacted to make arrangements for the 3rd dose to be administered.
Patient stated that her arm was a little swollen at the injection site and then it proceeded to become swollen around her entire arm. She described the swollen area the size of her fist. She visited her PCP and they gave her a Benadryl shot, Bactrim, naproxen and Zyrtec.
A lot of chest pains, so much they had to take pain reliever, hot and sweaty (fever), very tired, slept most of the next day.  Symptoms started approximately 11 1/2 hours after vaccine.
Patient received the first dose of the COVID vaccine on 12/28/20, and the second dose on 1/8/21 (11 days later instead of 21 days). The patient reported experiencing right eyelid and cheekbone numbness and a minor headache after the first dose. She had numbness to her right cheek again on 1/8/21 and some nausea that has resolved.  I spoke with the patient on 1/11/21 and she is feeling well.
This case was reported by a nurse via call center representative and described the occurrence of injection site injury in a 50-year-old female patient who received BOOSTRIX (batch number EC9A9, expiry date 22nd January 2019). Co-suspect products included KENALOG injection for drug use. On 17th January 2017, the patient received BOOSTRIX .5 ml and KENALOG Injection at an unknown dose and frequency. On 17th January 2017, several hours after receiving BOOSTRIX, the patient experienced injection site injury, injection site pain and injection site warmth. The action taken with KENALOG Injection was unknown. On an unknown date, the outcome of the injection site injury was not recovered/not resolved and the outcome of the injection site pain and injection site warmth were recovered/resolved. It was unknown if the reporter considered the injection site injury, injection site pain and injection site warmth to be related to BOOSTRIX. Additional details were provided as follows: The healthcare provider reported that the patient received BOOSTRIX in her left deltoid and experienced pain, warmth and an indentation in the arm a couple of hours after the vaccination. The patient concomitantly received KENALOG injections however, the nurse did not know the site of the KENALOG injection. The reporter did not provide the patient's date of birth or details of the person who administered the vaccine. It was unknown if the reporter considered the injection site indentation, injection site pain and injection site warmth in the arm to be related to KENALOG injection as well. The reported lot number (EC989) for BOOSTRIX did not exist and was updated to EC9A9, according to sales database.
Baby awoke during noc with arching of back and "foaming at the mouth".  "Fever" but mom did not take at time of temp. difficulty catching her breath. T-98.9 here today
An 18-year-old male patient had received a first dose, left deltoid, intramuscular injection of Menactra, lot number U1968AA, on 12 June 2007. The following day, the patient experienced body aches, headache, and severe light sensitivity. Concomitant medications included allergy injections. There was no illness at the time of vaccination. Relevant diagnostic testing was reported as none. At the time of this report, the patient had not recovered. The reporter in this case is the same is in case 2007-02213.
Injection site is now red, swollen, itchy, and warm to the touch. It has spread from the elbow to the shoulder
Breakthrough case admission after 2 vaccines Pfizer 3/26/21 Lot# ER8732;  Pfizer 4/16/21 Lot# Ew0169
Hives Prednisone 60mg x1 day, 40mg x 2 days, 30mg x 3 days, 20mg x 2 days, 10mg x 2 days.
Mom called 11/9 that child fainted in car after immunization on 11/7. She took him to ER after. He was fine now per mother on 11/9. Per ER note - no tests done. Dx syncope vasovagal.
Per pt's caregiver, he had chills, hives, itching, fatigue, swollen joints, an irregular EKG and PVC (premature vascular contractions). The irregular EKG & PVC is what I wanted to report since this is not considered typical with the Pfizer vaccine.
16 mo male ex 25 weeker, O2 dependent, (+) central apnea. Pt was given IPV 3, DTaP 3, Hib 3, Hep B 2 and approx. 5-10 min later developed urticarial rash on face, swelling of face and redness of face spreading to trunk. No SOB/wheezing. He had no rxn to imms previously. Given epinephrine and Sx's resolved after 5-10 min.
This spontaneous report received from a patient via a company representative concerned a patient of unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient takes care of himself, had no high blood pressure and walk on a treadmill. The patient did not have any history of heart issues. On an unspecified date, the patient was previously treated with Covid-19 vaccine ad26.cov2.s from an unspecified manufacturer (dose number in series: 1) (suspension for injection, route of admin, batch number: unknown, expiry: unknown) dose was not reported, 1 total, administered on for prophylactic vaccination. The reporter did not report any adverse events following vaccination with Covid-19 vaccine ad26.cov2.s (dose number in series 1). The patient received Covid-19 vaccine ad26.cov2.s (dose number in series: 2) (suspension for injection, route of admin, batch number: unknown and expiry: unknown) dose was not reported, 1 total, administered on 10-DEC-2021 for prophylactic vaccination. Concomitant medications included vitamins. On an unspecified date, the patient experienced irregular heart beats. Laboratory data (dates unspecified) included: Laboratory test (NR: not provided) not reported (dose number in series: 2). The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of irregular heart beats was not reported. This report was non-serious. Sender's Comments: V0- Medical assessment comment is not required as per standard procedure as case was assessed as non-serious.
pt recvd vax 1PM no side effects noted until 3AM when she awoke w/fever 105 & vomiting; pt recvd APAP until then fever has cont all day 102 w/APAP; called MD;
1) pain @ injection site started 9 hours after shot lasted 2 days 2) sinus cold the day after shot lasted 2 days. Not sure if related.  3) hives  about 1 week after shot. I had them on my arms,chest,top of feet,groin,buttocks and waist line. SECOND SHOT  1) pain @  injection site. Less then the first shot and only lasted a day. 2) hives mostly came up on my upper thighs. Not as bad as the first. They did not itch as much.
pt recvd vax & was found to be anti-HBC pos; pt has been contacted & is going to be treated as if does have clinical hep B;
I had 2 instances of Atrial Fibrillation after my vaccinations.  1st A-Fib about 2 weeks after my first shot. 2nd A-Fib episode
Pain/redness/swelling developed within 12 hrs of vaccine in arm required visit to ER. Treatment with antibiotics and pain meds and anti-inflammation meds. Entire upper arm.  Has stabilized.
Approx. 20 days after 1st Shot, and about 10 days prior to second shot, I felt a nodule in my neck below the mandible on the left side. It seems to have gotten larger and currently is approx 1" in diameter. My physician is having me follow-up with tests as to what is going on with it and to determine whether it is a  swollen lymph gland resulting from the Covid 19 immunizations, or something else. She has assessed it as a "Submandibular lyphaedenopathy" thus far as of unknown origin and the tests are to "evaluate the submandibular node", I am setting up for testing tomorrow and she will receive reports of their evaluations and any further actions to be taken.
light headache; Low grade fever; Muscle ache; Pain; This is a spontaneous report from a contactable consumer (parent) reported that a 49-year-old female patient received single dose of (BNT162B2, Solution for injection, lot number was not provided), via an unspecified route of administration on the left arm on 18Dec2020 for covid-19 immunization. Medical history included ongoing hypertension that was diagnosed when she was 32-years-old, after she gave birth to her second child; she was diagnosed with COVID-19 on 25Aug2020, and now was 4 months out from having COVID-19; reportedly she was tired and had a lot of "nervously" feeling, like heart palpitations before she took the COVID-19 vaccine. There were no concomitant medications. On 19Dec2020, the patient experienced light headache, low grade fever, muscle ache and pain. The patient underwent lab tests and procedures which included weight: 212-213 lbs on an unspecified date. The outcome of the events was recovered on 19Dec2020.   Information about lot/batch number has been requested.
administrated an expired dose; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a patient who received Flu Seasonal QIV Dresden (Fluarix Tetra 2021-2022 season) (batch number unknown, expiry date 30th June 2022) for prophylaxis.   Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Fluarix Tetra 2021-2022 season and Fluarix Tetra Pre-Filled Syringe Device. On an unknown date, unknown after receiving Fluarix Tetra 2021-2022 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 05-OCT-2022 Reporter's Comments: The project manager reported on that a patient was administrated with an expired dose of Fluarix QIV.  No adverse event was reported.  The reporter was consented to follow up.  No patient's identifiers provided no batch number and expiration date provided no vaccination date provided. Additional Supportive Information:  The vaccine was already expired and was administered to the patient, which led to expired vaccine used.
Within 8 hours of injection, I started to get headaches which have been consistent until today. Today 04/13/21, I am now feeling a slight pain in my left arm. I am starting to feel flu like symptoms.
Initial and follow up information has been received from a Licensed Practical nurse and a physician concerning a female patient who was vaccinated with a first dose of Gardasil. She developed hives within 2-3 hours of receiving the injection. Unspecified medical attention was sought. The patient was not recovered. The nurse considered hives to be disabling she was not available for follow up, and when the physician was contacted, he could not provide any information regarding why the nurse considered the event disabling. He had not been able to contact the patient. He had no further information regarding her outcome. Additional information has been requested.
ROTATEQ after 15 weeks old(4 months old).; Information has been received from a nurse practitioner referring to a 4 months old patient. The patient's historical condition, concomitant medications and drug reactions or allergies were not reported.  On an unknown date, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent(ROTATEQ)(dose, frequency, route, lot # and expiration date were not reported) for prophylaxis(inappropriate schedule of product administration). Nurse Practitioner wanted to know if the patient should continue with the regimen or stop.
L arm-4 vaccines to L upper arm. 4" x 3" reddened region, circular to LD region.  Itching, warm to touch.  Tetanus-1999 no reaction.  Polio previous - no reaction.
hurts on his side; This is a spontaneous report received from a Pfizer sponsored Program Support from a contactable consumer (patient). A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported.  The patient scheduled for the 2nd shot 29Mar2021 (can't drive a car). The 1st shot had side effects (hurts on his side). He wanted to know if he can reschedule. The outcome of the event was unknown.      Information on the lot/batch number has been requested.
swelling in the left side of face; painful wrist; being sick for 2 days; heart palpations; dizziness; nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (being sick for 2 days), PALPITATIONS (heart palpations), SWELLING FACE (swelling in the left side of face), DIZZINESS (dizziness) and NAUSEA (nausea) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced ILLNESS (being sick for 2 days), PALPITATIONS (heart palpations), DIZZINESS (dizziness), NAUSEA (nausea) and HEADACHE (Headache). On 08-Mar-2021, the patient experienced SWELLING FACE (swelling in the left side of face) and ARTHRALGIA (painful wrist). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 14-Feb-2021, ILLNESS (being sick for 2 days), NAUSEA (nausea) and HEADACHE (Headache) had resolved. At the time of the report, PALPITATIONS (heart palpations), SWELLING FACE (swelling in the left side of face), DIZZINESS (dizziness) and ARTHRALGIA (painful wrist) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
Patients were administered "expired vaccines"/ the vial was punctured for more than 24 hours; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients were administered "expired vaccines"/ the vial was punctured for more than 24 hours) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 062E21A and 088D21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients were administered "expired vaccines"/ the vial was punctured for more than 24 hours). On 23-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Patients were administered "expired vaccines"/ the vial was punctured for more than 24 hours) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were reported. Date the vial was initially stored in the refrigerator:14Sep2021. Date(s) of administration of vaccine when applicable: 23Sep2021.    This case was linked to MOD-2021-328710 (Patient Link).
I got sore throat; cough; fever; tiredness; tightness in chest for 2 weeks and I took Paxlovid; Albuterol; Promethazine; Benzonathee and throat lozenges.
1st vax entire arm stiff about 3-4 days; reaction occurred immed p/inject; 2nd vax stiffness from neck all the way down arm where inject occurred; pt had rash across face & chest & felt washed out, weak w/no appetite; low grade fever;
On 4 13 10 father called in regards to rash on forehead and upper trunk (had low grade fever 99.3 degrees F since day of vaccination).
Intense itch on trunk of body/midriff area. Large red welt like marks there. Also smaller red, itchy marks on upper chest above breast area. Subsided after topical cortisone cream applied.  Most marks gone by morning. Returned on Friday, 2/19 only on midriff and smaller in dimension.  Lasted through night and morning. Itch, quite intense, reappeared. A light red mark is visible now-2/20@10:35 am. Itch has lessened.
within 5-15 minutes of injection: soreness in at injection site spread throughout arm, hand, and fingers, numbness in face - cheek, eye, nose on right side (felt like I had novocaine for right side dental work), hoarseness, cankor or cold sore (not sure I know the difference) on right lower lip, warm sensations in right calf muscle and right foot  within 15-60 minutes tender lymph node right armpit, fatigued muscles in legs, brain fog
Shivering, altering between hot and cold, pains shooting through legs and arms, headache, stomache, feeling faint when standing or walking for any length of time. I've had vaccines before and never had this type of reaction.
Fever of 100.8 approximately 13 hours after vaccination. Resolved with 800 mg ibuprofen. Headache, muscles aches and general feeling of malaise the following day.
The pt has a lack of sero conversion - negative titer on 2/16/2001.
he felt achey and weak for a day or two then had syncope then he had syncope again this morning. found to have NSTEMI. received PCI with a DES x1. recovered and discharged home
On the morning of 6/2/2022, I began to have symptoms that I now know are those of COVID. It started with a sore throat. I then had the sniffles. On 6/4/2022, I then also lost my sense of taste and smell. I took a home test for COVID on the morning of 6/2/2022, and the result was positive. I went to the hospital testing site at 1 PM the same day and took a PCR test, and the result was again positive. I called my doctor's office and requested PAXLOVID, but I was told I didn't qualify for a prescription, because there were concerns that it would interact negatively with one of the medications I already take. I wasn't prescribed anything and was just advised to take TYLENOL and stay hydrated. If my symptoms worsened or I had trouble breathing, I was to go to the emergency room. Fortunately, it has not come to that. At the time of this writing, I still have some head congestion and can't taste or smell. Otherwise, I feel fine.
9JAN98 had onset of rash-flat red round & blanches-that started on abd & spread to face, back, thighs, & diaper area;approx 10-14 days p/vax;
Information has been received from a physician concerning a 22 year old female with mild asthma and a history of CIN grade I (2003, 2005 and 2006) and a benign pigmented lesion removed from her inner thigh (2006) who on 08-FEB-2007 was vaccinated IM into the right arm with a 0.5 ml dose of Gardasil (yeast) (lot # 654535/0960F). Concomitant therapy included oral hormonal contraceptives (unspecified). Three on 11-FEB-2007 the patient developed two raised areas of hyperpigmented skin in the area of the injection site. The areas are 4 x 4 mm and 3 x 3 mm. The areas are described as are nevus like in appearance, linear, surrounded by erythema and painful. The patient is being evaluated for a "possible skin rash." The patient had not yet recovered from her experiences. Additional information has been requested.
2 days after getting Zostavax, he had the same lip irritation that he can get like a fever blister (cold sore) breaks out. This lasted one week. Never a a fever blister.
hot and cold chills; body aches; tired; nausea; did not sleep the rest of the night; This is a spontaneous report from a contactable consumer. A 32-year-old female received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number: EL0142, via an unspecified route of administration in the left arm on 12Jan2021 10:30 at a SINGLE DOSE for covid-19 immunization. Medical history included Gluten and dairy allergy. Prior vaccination, patient has had covid-19 from an unknown date to 30Dec2020. Patient was not pregnant during vaccination. Concomitant medications included curcumin, acetylcysteine, ascorbic acid, quercetin, vitamin b complex, vitamin c and colecalciferol. The patient previously took minocycline and zithromax and experienced allergy to both. The patient received the vaccine on 12Jan2021 at 10:30 and started feeling symptoms hot and cold chills, body aches on 13Jan2021 around 1:00 AM. She did not sleep the rest of the night and throughout the day was tired, chills, body aches, nausea. Patient also stated that she started her period the day she received the vaccine which she was not sure if did help her immune system. The outcome of events was recovering. Patient did not received any treatment due to the events. Since the vaccination, the patient hasn't been tested for COVID-19.  No follow-up attempts are possible. No further information is expected. Information on the lot/batch number has been obtained.
on 1/17/21 client noticed red spot about 2 in. wide on her arm where shot was given. Noted soreness. Another spot formed on her chest, shoulder, and neck also similar in appearance. On 1/18/21 client developed HA, fatigue, body aches, nausea. PCP notified, client seen for evaluation, PCP took pictures. On 1/19/21 client developed diarrhea.
Yellow Fever vaccination given on 3/27/2009 @ 10:20 a.m. Student returned to Clinic at 11:35 a.m. for swelling of lower lip, left lower lip to middle of lip and local redness and swelling at injection site of right upper arm.  Student used his albuterol MDI inhaler 2 puffs @ 11:25 a.m. prior to coming to clinic for shortness of breath.  Student was assessed and treated with nebulizer treatment at ll:40 a.m. Student was also given cetirizine HCl 10 mg one tablet and pepcid 20 mg one tabelet po @ 11:51 p.m. In addition a cold pack was placed on Right upper arm and secured in place with ace wrap.  Student denied shortness of breath or difficulty breathing or swallowing,  skin warm, dry & pink; vital signs normal, Oxygen saturation upon arrival was 98%.  Student was observed at the clinic till 12:50 p.m. and released from clinic in stable condition with post nebulizer oxygen saturation of 98%.  Student returned to clinic at 2:15 per ARNP for Treatment and FU Plan which included Zyrtec 10 mg po one tablet times 3 days and pepcid 20 mg one tablet po times 3 days, No running until 3/28/2009 and only if asymptomatic; use albuterol MDI before running; Student released from Clinic with swelling decreased to almost normal size, no shortness of breath or dyspnea.  F/U PRN @ Clinic or urgent care facility.
Acute hypoxemic respiratory failure due to COVID-19 pneumonia. Patient was empirically started on antibiotics due to elevated procalcitonin he received IV Decadron, IV Lasix, Lovenox, vitamin-C, zinc.  He completed remdesivir.  He he made good progress and was down to 1 L to room air on day of discharge. Vitals on day of discharge he had a temp of 98.1, heart rate 66, blood pressure 124/82, respiratory rate of 17, O2 saturations of 92% on room air